Literature DB >> 10068586

Interaction between group A streptococci and the plasmin(ogen) system promotes virulence in a mouse skin infection model.

Z Li1, V A Ploplis, E L French, M D Boyle.   

Abstract

Group A streptococci are capable of acquiring a surface-associated, unregulatable plasmin-like enzymatic activity when incubated in human plasma. The effect of this enzymatic activity on virulence of group A isolate CS101 was examined in a mouse skin infection model. Initial studies demonstrated enhanced virulence for bacteria preincubated in human plasma but not in plasminogen-depleted plasma. A direct correlation between surface-associated enzymatic activity and virulence was not observed; however, an association between virulence and the assembly of a surface-associated plasminogen activator that could activate mouse plasminogen was noted. This activity enhanced virulence in wild type but not in plg-/- plasminogen-deficient mice. These results support the hypothesis that acquisition of a surface-associated plasmin(ogen)-dependent enzymatic activity can contribute to the virulence of group A streptococcal invasive infections.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10068586     DOI: 10.1086/314654

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  18 in total

1.  Coevolutionary patterns in plasminogen activation.

Authors:  Inna P Gladysheva; Ryan B Turner; Irina Y Sazonova; Lin Liu; Guy L Reed
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-23       Impact factor: 11.205

2.  Restoration of Mga function to a Streptococcus pyogenes strain (M Type 50) that is virulent in mice.

Authors:  B Limbago; K S McIver; V Penumalli; B Weinrick; J R Scott
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

Review 3.  Pathogen activators of plasminogen.

Authors:  I M Verhamme; P R Panizzi; P E Bock
Journal:  J Thromb Haemost       Date:  2015-06       Impact factor: 5.824

4.  In Vivo Tracking of Streptococcal Infections of Subcutaneous Origin in a Murine Model.

Authors:  Richard W Davis; Heather Eggleston; Frances Johnson; Matthias Nahrendorf; Paul E Bock; Tiffany Peterson; Peter Panizzi
Journal:  Mol Imaging Biol       Date:  2015-12       Impact factor: 3.488

Review 5.  Molecular insight into invasive group A streptococcal disease.

Authors:  Jason N Cole; Timothy C Barnett; Victor Nizet; Mark J Walker
Journal:  Nat Rev Microbiol       Date:  2011-09-16       Impact factor: 60.633

6.  Plasminogen binding by group A streptococcal isolates from a region of hyperendemicity for streptococcal skin infection and a high incidence of invasive infection.

Authors:  Fiona C McKay; Jason D McArthur; Martina L Sanderson-Smith; Sandra Gardam; Bart J Currie; Kadaba S Sriprakash; Peter K Fagan; Rebecca J Towers; Michael R Batzloff; Gursharan S Chhatwal; Marie Ranson; Mark J Walker
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

7.  Role of the C-terminal lysine residues of streptococcal surface enolase in Glu- and Lys-plasminogen-binding activities of group A streptococci.

Authors:  Anne Derbise; Youngmia P Song; Sonia Parikh; Vincent A Fischetti; Vijay Pancholi
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

8.  Binding and activation of host plasminogen on the surface of Francisella tularensis.

Authors:  Shawn R Clinton; James E Bina; Thomas P Hatch; Michael A Whitt; Mark A Miller
Journal:  BMC Microbiol       Date:  2010-03-12       Impact factor: 3.605

9.  Molecular cloning and characterization of two Helicobacter pylori genes coding for plasminogen-binding proteins.

Authors:  Klas Jönsson; Betty P Guo; Hans-Jürg Monstein; John J Mekalanos; Göran Kronvall
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-09       Impact factor: 11.205

10.  Staphylococcus aureus exploits cathelicidin antimicrobial peptides produced during early pneumonia to promote staphylokinase-dependent fibrinolysis.

Authors:  Marissa H Braff; Amanda L Jones; Shawn J Skerrett; Craig E Rubens
Journal:  J Infect Dis       Date:  2007-03-15       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.